Sign in

CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company

TriSalus Life Sciences, Inc.

Sign in to watch
Ticker
TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853009869
Phone
415 336 8917
Business address
6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Former names
MedTech Acquisition Corp, MedTech Acquisition Corporation

Securities

  • TLSI Common Stock Nasdaq
  • TLSIW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,113
in 3 filings

Net −$4,113. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Marshak Richard −$1K Chief Commercial Officer sold <1% of stake
  2. Stevens Jennifer −$1K Chief Regulatory Officer sold <1% of stake
  3. Cox Bryan F. −$1K Chief of Research sold <1% of stake

Reading 26 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-05 Cox Bryan F. Chief of Research Sale −296 $4.39 $1K 162,805
2026-10-05 Marshak Richard Chief Commercial Officer Sale −325 $4.39 $1K 127,994
2026-10-05 Stevens Jennifer Chief Regulatory Officer Sale −316 $4.39 $1K 123,794
2026-10-05 Szela Mary T CEO and President Shares withheld for taxes −2,693 $4.38 $12K 1,074,990
2026-07-01 Patience David Chief Financial Officer Shares withheld for taxes −14,650 $4.46 $65K 261,107
2026-06-30 Szela Mary T CEO and President Grant or award +3,990 $3.87 $15K 1,077,683
2026-06-30 Marshak Richard Chief Commercial Officer Grant or award +561 $3.87 $2K 128,319
2026-06-29 Marshall Richard Henry Chief Medical Officer Grant or award +60,000 90,000
2026-06-29 Marshall Richard Henry Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +120,000 253,000
2026-05-15 Marshak Richard Chief Commercial Officer Sale −543 $2.67 $1K 125,101
2026-05-15 Wahlstrom Mats Director Purchase +60,000 $2.53 $152K 147,555
2026-05-15 Stansky Michael P Director Purchase +410,000 $2.50 $1.0M 1,240,722
2026-05-15 Stansky Michael P Director Purchase +200,000 $2.50 $500K 399,698
2026-05-15 Szela Mary T CEO and President Purchase +39,682 $2.59 $103K 1,065,215
2026-05-15 Patience David Chief Financial Officer Purchase +7,100 $2.43 $17K 275,757
2026-05-15 Gordon Gary B. Director Purchase +10,000 $2.46 $25K 72,510
2026-05-14 HICKS KERRY R Director Grant or award +28,201 542,790
2026-05-14 HICKS KERRY R Director Grant or award · Director Stock Option (right to buy) +56,403 145,625
2026-05-14 Wahlstrom Mats Director Grant or award +37,602 53,329
2026-05-14 Wahlstrom Mats Director Grant or award +34,226 87,555

Page 1 of 9 · 161 trades